VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$0.64
-0.05 (-7.10%)
As of May 16, 9:44 PM ET ·
Financial Highlights (FY 2026)
Revenue
24.17M
Net Income
-29,331,004
Gross Margin
60.4%
Profit Margin
-121.4%
Rev Growth
+2.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 24.17M 23.49M 4.42M 4.57M
Gross Profit 14.61M 14.20M 2.05M 2.12M
Operating Income -27,562,274 -24,111,631 949.1K 872.8K
Net Income -29,331,004 -25,658,926 675.6K 727.9K
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Rev Growth +2.9% +2.9% +3.6% -1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 6.54M 5.85M
Total Equity 8.58M 7.69M
D/E Ratio 0.76 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,660,002 -23,694,597 1.16M 1.26M
Free Cash Flow 869.0K 665.9K